Jump to content
Powered by
  • BIOPRO BW
  • Healthcare industry
  • Bioeconomy
  • Project pages
    • Telemedicine BW
    • MDR & IVDR

Healthcare industry

Main navigation

  • Start page
  • Healthcare industry BW

    Healthcare industry BW

    Close
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles

    Articles

    Close
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events

    Events

    Close
  • Databases

    Databases

    Close
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services

    BIOPRO services

    Close
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • de
  • en
Show menu

You are here:

  1. Home
  2. Search
Show:Results per page
  • 25Show results
  • 50Show results
  • 75Show results

Search Results

  • Article - 22/12/2014 A section of metabolic pathways visualised with bioinformatics analyses is shown at the top. The data peaks in the background are shown in 3D. The higher the peaks, the more purple the peaks get. <br />

    Bioinformaticians shed light into the data jungle

    In recent years, the University of Tübingen has developed a tightly integrated service structure for the computer-based management of life sciences data. This structure is the point of contact for all those that produce or work with “omics” data – in Tübingen and beyond.

    https://www.gesundheitsindustrie-bw.de/en/article/news/bioinformaticians-shed-light-into-the-data-jungle
  • Article - 22/12/2014 22598_de.jpg

    Fighting hepatitis viruses with their own weapons

    Virologist Prof. Dr. Stephan Urban from the University of Heidelberg has been awarded the DZIF Prize for Translational Infection Research for the discovery and development of a promising peptide drug for the treatment of hepatitis B virus infections. The peptide prevents viruses from entering the liver cells, and is also effective against hepatitis D infection. Hepatitis D is the deadliest of all viral liver diseases and no specific antiviral…

    https://www.gesundheitsindustrie-bw.de/en/article/news/fighting-hepatitis-viruses-with-their-own-weapons
  • Article - 22/12/2014 22613_de.jpg

    Large-scale urology project: cell therapy for the treatment of stress incontinence

    The first and so far only clinical DFG research group on urology is being coordinated by a team from Tübingen. The team is developing a cell-based therapy for the regeneration of the urethral sphincter. Clinicians, life scientists and engineers are working together to try and find a causal therapy of stress incontinence.

    https://www.gesundheitsindustrie-bw.de/en/article/news/large-scale-urology-project-cell-therapy-for-the-treatment-of-stress-incontinence
  • Article - 22/12/2014 Schematic showing T-cell activation without and without CTLA4.

    The immune system – both weak and overreactive in the absence of CTLA4

    The ability to recognise a pathogen and combat it effectively is certainly one of the most complex and sophisticated processes the human body has evolved. People with an immunodeficiency or autoimmune disease may have a genetic defect in one of the genes involved in the immune response. Working with immunologists from London scientists Desire Schubert and Prof. Dr. Bodo Grimbacher from the Centre for Chronic Immunodeficiency CCI at the Freiburg…

    https://www.gesundheitsindustrie-bw.de/en/article/news/the-immune-system-both-weak-and-overreactive-in-the-absence-of-ctla4
  • Article - 15/12/2014 22544_de.jpg

    From HIV structure to new AIDS therapies

    The building blocks of the viral protein capsid are rearranged as HI viruses mature into infectious AIDS-causing agents. Researchers from Heidelberg have made these structural changes visible on the molecular level. The findings could potentially be used for developing much-needed new AIDS therapeutics.

    https://www.gesundheitsindustrie-bw.de/en/article/news/from-hiv-structure-to-new-aids-therapies
  • Article - 15/12/2014 Schematic showing how cardiac muscle cells are prepared, and how cell nuclei and the genetic material are isolated.

    Heart muscle cell 1.0 and 2.0 – two epigenetic programmes in one cell

    All the cells in an organism have to adapt to changing requirements as they develop and grow - including muscle cells in the heart. Crucial to this process are the cells’ growth in size and epigenetic factors that play a role in modulating the expression of various genes. The role of epigenetics in cancer development has been the focus of research for quite some time. The question is, what role do epigenetic factors play in the development of the…

    https://www.gesundheitsindustrie-bw.de/en/article/news/heart-muscle-cell-1-0-and-2-0-two-epigenetic-programmes-in-one-cell
  • Article - 08/12/2014 Portrait of Stefan Hell

    Stefan Hell – a Nobel Prize for a lateral thinker

    Stefan Hell was awarded the Nobel Prize in Chemistry for the development of STED fluorescence microscopy which has made it possible to obtain optical images well below the optical diffraction limit. However, Hell does not really see himself as a developer. His passion is scientific principles, the identification of how things are connected and the exploration of new, uncharted paths.

    https://www.gesundheitsindustrie-bw.de/en/article/news/stefan-hell-a-nobel-prize-for-a-lateral-thinker
  • Article - 01/12/2014 22507_de.jpg

    Stem cell research for preventing radiation-induced developmental damage

    Although ionizing radiation is known to cause cell damage and genetic modifications, its effects on embryonic development are still poorly understood. This is why Prof. Dr. Suzanne Kadereit from the Albstadt-Sigmaringen University of Applied Sciences is involved in a cooperative project that uses human embryonic stem cells for studying the effects of ionizing radiation on prenatal brain development. She heads up the only university of applied…

    https://www.gesundheitsindustrie-bw.de/en/article/news/stem-cell-research-for-preventing-radiation-induced-developmental-damage
  • Article - 28/11/2014 18963_de.jpg

    Martin Plenio - turning Ulm’s quantum biology into a technology forge

    Quantum biology has the potential to become the next big research coup. Professor Martin Plenio, 46, director of the Institute of Theoretical Physics at Ulm University and one of the world’s leading quantum technologists, is right at the forefront. He has been Alexander von Humboldt Professor since 2009, and holds a part-time professorship at Imperial College London, where he was formerly chair of quantum physics.

    https://www.gesundheitsindustrie-bw.de/en/article/news/martin-plenio-turning-ulm-s-quantum-biology-into-a-technology-forge
  • Press release - 26/11/2014 15740_de.jpg

    Curetis Closes EUR 14.5 Million Extension of Series B Financing

    Curetis AG wins new investors QIAGEN and LSP-HEF, committing EUR 7 million. Hence Curetis is well financed into 2017. Curetis AG, a developer of next-level molecular diagnostic solutions, today announced it has closed a EUR 14.5 million extension of its Series B financing round, which was originally led by HBM Partners in April 2013.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/curetis-closes-eur-14-5-million-extension-of-series-b-financing
  • Article - 24/11/2014 Three-dimensional microscopic representation of a synthetic vesicle that is invaded by bacteria.

    Lipid zipper triggers bacterial invasion

    Millions of people die each year from infections both in developing and industrial countries. There is still no effective treatment for a large number of diseases caused by pathogens. In order to treat infectious diseases effectively, we need to understand the mechanisms that bacteria use to infect human cells. The cytoskeleton of the host cell usually plays a key role in this process. Researchers at the University of Freiburg have discovered a…

    https://www.gesundheitsindustrie-bw.de/en/article/news/lipid-zipper-triggers-bacterial-invasion
  • Article - 17/11/2014 Microscope image of two nerve cells that are connected with each other.<br />

    About synapses and learning

    You can’t teach an old dog new tricks – the old proverb is not totally true. It is now known that the modulation of synaptic functions, including the formation of new neurons, still takes place in old age, although to a lesser extent than in childhood. The human brain stores memories in the form of neural activity patterns. Structural plasticity appears to be the basis for all learning processes. Physician Thomas Hainmüller and Prof. Dr. Marlene…

    https://www.gesundheitsindustrie-bw.de/en/article/news/about-synapses-and-learning
  • Guest article - 10/11/2014 22325_de.jpg

    Six Months Research in an Incredible City at the other Side of the World

    The fellowship program “Research stay for application-oriented bioscientists and biotechnologists in Shanghai and Jiangsu/China” funded by the Baden-Württemberg Ministry of Science, Research and the Arts enabled Sonja Blasche to spend six months at the Minhang Campus of the Jiao Tong University in Shanghai. During this time she worked in the laboratory of Professor Zhao Liping, an internationally known expert on microbial communities and the…

    https://www.gesundheitsindustrie-bw.de/en/article/news/six-months-research-in-an-incredible-city-at-the-other-side-of-the-world
  • Dossier - 10/11/2014 22065_de.jpg

    Cell and gene therapies: from bench to bedside

    While cell therapy has become standard treatment for a number of blood cancers, most cell and gene therapy approaches for the treatment of hereditary and metabolic diseases, neurodegenerative disorders and cancer are still in the experimental phases or early clinical trials. However, recent successes give rise to the hope that cell and gene therapies will in future make important contributions to previously incurable diseases.

    https://www.gesundheitsindustrie-bw.de/en/article/dossier/cell-and-gene-therapies-from-bench-to-bedside
  • Article - 10/11/2014 22262_de.jpg

    Alzheimer: amyloid-beta triggers mitochondrial dysfunction

    Neurons are very sensitive to disturbances and many different functions are no longer able to work efficiently when the power supply is impaired. Prof. Dr. Chris Meisinger and his team at the Institute of Biochemistry and Molecular Biology at the University of Freiburg have found that amyloid-beta peptides block important enzymes in the mitochondria resulting in mitochondrial dysfunction.

    https://www.gesundheitsindustrie-bw.de/en/article/news/alzheimer-amyloid-beta-triggers-mitochondrial-dysfunction
  • Press release - 05/11/2014 22360_de.jpg

    Orphan drug status for Synovo's immune modulator SYD003

    The European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA) have granted orphan drug designation to Synovo's investigational compound SYD003, a first in class tumour-targeted immune modulator.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/orphan-drug-status-for-synovo-s-immune-modulator-syd003
  • Article - 03/11/2014 Photo of Prof. Jucker browsing through a journal.

    Dementia and the prion principle

    Prions are misfolded proteins that are associated with diseases such as BSE, Creutzfeldt-Jakob disease and scrapie. What makes prions particularly dangerous is their ability to induce properly folded proteins to convert into misfolded prion forms. This principle seems to be more widespread than previously thought. Dr. Mathias Jucker from the University of Tübingen and his American colleague Lary Walker from Emory University have put forward a…

    https://www.gesundheitsindustrie-bw.de/en/article/news/dementia-and-the-prion-principle
  • Article - 27/10/2014 The photo shows a drug production line.<br />

    Takeda GmbH in Singen – pharmaceutical development and production under one roof

    From stomach protection agents to drugs for the treatment of respiratory distress in preterm infants – Singen-based Takeda GmbH plays an important role as a competence centre for drugs in liquid and semi-solid dosage form within the Japanese pharmaceutical company’s global network. Besides the production of around 68 million packages per year, the company’s production site in Singen also focuses on drug development. The company’s CMC Centre…

    https://www.gesundheitsindustrie-bw.de/en/article/news/takeda-gmbh-in-singen-pharmaceutical-development-and-production-under-one-roof
  • Article - 20/10/2014 The photo shows three QIAGEN Lake Constance staff in the laboratory with a mobile diagnostics device.<br /> <br />

    QIAGEN Lake Constance – pocket-sized laboratories for the efficient identification of pathogens

    Quick, simple and decentralized – this is how QIAGEN Lake Constance GmbH envisages diagnostics applications in the future. The Stockach-based QIAGEN subsidiary develops test systems for point-of-need diagnostics, i.e. tests that can be carried out in close proximity to the sample collection point, for example in GP surgeries. They enable the rapid identification of pathogens, and as a result the timely initiation of suitable treatment.

    https://www.gesundheitsindustrie-bw.de/en/article/news/qiagen-lake-constance-pocket-sized-laboratories-for-the-efficient-identification-of-pathogens
  • Article - 20/10/2014 Schematic showing an eyeball, action potentials and electron microscope images.

    First ever eye gene therapy close to clinical testing

    There are many different retinal diseases simply because many different steps of the visual process can be affected. However, they all have one thing in common: correction of the relevant defective gene currently provides the only possibility of permanent cure. Prof. Dr. Mathias Seeliger and his group of researchers at the Institute of Ophthalmic Research at the University Hospital in Tübingen is specifically focused on the development of gene…

    https://www.gesundheitsindustrie-bw.de/en/article/news/first-ever-eye-gene-therapy-close-to-clinical-testing
  • Article - 20/10/2014 22216_de.jpg

    Michael Schindler: HI virus and host interactions

    Prof. Dr. Michael Schindler explores the interaction between viruses and their human host cells on the molecular level. His specific interest is HI virus infections and the mechanisms the virus uses to attack the human immune system. Schindler’s eventual aim is to identify a new target for the therapy of HIV infections. In April 2014, Schindler was appointed head of the Department of Molecular Virology of Human Infectious Diseases at the…

    https://www.gesundheitsindustrie-bw.de/en/article/news/michael-schindler-hi-virus-and-host-interactions
  • Article - 13/10/2014 The photo shows a lit cigarette lying on an ashtray.

    Concepts for breaking the smoking habit

    Giving up smoking would mean an estimated 30 percent reduction in cardiovascular disease and a 90 percent reduction in cases of lung cancer, and that’s just in men. There are many arguments for giving up smoking. However, despite being highly motivated, many smokers fail to do so. Professional help is therefore available in the form of behavioural- and pharmacotherapy. The relevant guidelines in Germany have just been amended and now recommend a…

    https://www.gesundheitsindustrie-bw.de/en/article/news/concepts-for-breaking-the-smoking-habit
  • Article - 13/10/2014 The photo shows a microfluidic chip and the sample-processing chambers.

    Personalised cancer therapy based on microRNA analysis

    microRNAs are not just required for the regulation of gene expression, their expression signatures also allow conclusions to be drawn on the type and progression of cancer. Sensovation AG is therefore working with partners from industry and clinical research to develop an automated microRNA analysis platform that can detect and evaluate microRNA signatures faster than has previously been possible. The system is designed to make it easier to…

    https://www.gesundheitsindustrie-bw.de/en/article/news/personalised-cancer-therapy-based-on-microrna-analysis
  • Article - 13/10/2014 21907_de.jpg

    Data mining is likely to play an increasing role in clinical development

    Data mining still plays a minor role in the research-based pharmaceutical industry. But this is likely to change in the future. Mathematician Hans-Jürgen Lomp predicts that exploratory data analysis will be used to a greater extent in the future. Lomp is the Global Head of Statistics in Boehringer Ingelheim Pharma GmbH & Co KG’s Department of Medical Data Service and Biostatistics in Biberach.

    https://www.gesundheitsindustrie-bw.de/en/article/news/data-mining-is-likely-to-play-an-increasing-role-in-clinical-development
  • Press release - 09/10/2014 22223_de.jpg

    Stefan Hell - Nobel Prize in Chemistry

    For the second time a researcher at the DKFZ has been awarded the highest distinction in science: Professor Stefan Hell, director of the Max-Planck Institute for Biophysical Chemistry in Göttingen and department head at the DKFZ, has been awarded this year´s Nobel Prize in Chemistry for his pioneering work in the field of ultra high resolution fluorescence microscopy. This follows the 2008 Nobel Prize in Medicine for Harald zur Hausen.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/stefan-hell-nobel-prize-in-chemistry
  • Part 2 - 06/10/2014

    Expert interview: How are the prices of innovative diagnostic and medical devices determined?

    While there are specific regulations in Germany for the reimbursement of medicines, funding for molecular diagnostics products is complex and virtually non-existent. There is hardly any medical insurance cover for medical devices, which therefore tend to be sold on the open market. The question therefore arises as to how a reasonable price can be determined for innovative diagnostic methods and tools. In the second part of the interview conducted…

    https://www.gesundheitsindustrie-bw.de/en/article/news/expert-interview-how-are-the-prices-of-innovative-diagnostic-and-medical-devices-determined
  • Article - 29/09/2014 The photo shows a multi-well plate used for the automated and parallel analysis of many samples.

    myPOLS Biotec UG - made-to-measure enzymes for diagnostics and research

    The company myPOLS Biotec UG, a spin-off from the University of Konstanz, specializes in services involving DNA and RNA polymerases and creates artificial enzymes by evolution in test tubes. These next-generation polymerases can be used for many research and diagnostics applications. myPOLS Biotec’s polymerases are promising enzymes for future applications with the potential to make the detection of pathogens and DNA analysis faster and easier.

    https://www.gesundheitsindustrie-bw.de/en/article/news/mypols-biotec-ug-made-to-measure-enzymes-for-diagnostics-and-research
  • Article - 29/09/2014 22098_de.jpg

    Andrei Lupas – fascination for the complex world of proteins

    Prof. Dr. Andrei Lupas is a molecular biologist and director of the Department of Protein Evolution at the Max Planck Institute (MPI) for Developmental Biology in Tübingen. He became fascinated by the incredible complexity of proteins early on during his scientific career. His work focuses on the use of laboratory and computational methods to solve the question as to how a simple amino acid chain becomes a protein ‘nanomachine’. Lupas and his…

    https://www.gesundheitsindustrie-bw.de/en/article/news/andrei-lupas-fascination-for-the-complex-world-of-proteins
  • Guest article - 22/09/2014 22076_de.jpg

    Experience report: Six months Shanghai

    Sebastian Giese, a doctoral student at the University of Freiburg, spent six months in Shanghai with funding from a Baden-Württemberg Ministry of Science, Research and the Arts China scholarship. Below, Sebastian tells us about his impressions of the country and its people and his experiences in the megacity.

    https://www.gesundheitsindustrie-bw.de/en/article/news/experience-report-six-months-shanghai
  • Part 1 - 22/09/2014 The photo shows different tablet packages and an open wallet mit coins and banknotes.<br />

    Expert interview: How are the prices of new pharmaceuticals determined?

    Healthcare in Germany is quite good. Pharmaceutical and biotechnology companies carry out research in order to improve it further. The question is, how can a fair price for innovative drugs be determined? BIOPRO Baden-Württemberg GmbH has talked to Dr. Manfred Caeser, a specialist in pricing and reimbursement at LSCN Ltd.

    https://www.gesundheitsindustrie-bw.de/en/article/news/expert-interview-how-are-the-prices-of-new-pharmaceuticals-determined
  • Article - 15/09/2014 21978_de.jpg

    Mesenchymal stromal cells: promising cell therapy candidates

    Mesenchymal stromal cells MSC are increasingly moving into the spotlight as the beacon of hope for somatic cell therapies. The biomedical research community is currently carrying out more than 300 clinical trials to investigate their suitability for a broad range of indications. Prof. Schrezenmeier professor of transfusion medicine and medical director at the Institute for Clinical Transfusion Medicine and Immunogenetics IKT in Ulm is involved in…

    https://www.gesundheitsindustrie-bw.de/en/article/news/mesenchymal-stromal-cells-promising-cell-therapy-candidates
  • Article - 15/09/2014 Photo of Dr. Michael Kormann.

    Gene therapies for pulmonary disease are close to final development

    Gene therapy currently offers the only chance of curing genetic diseases such as cystic fibrosis and beta thalassaemia. Gene therapy is the replacement or correction of a mutated gene with DNA that encodes a functional gene. Intensive research has been going on in this field for many years however only a handful gene therapies are available at this point in time. Dr. Michael Kormann junior professor at the Childrens Hospital at the University of…

    https://www.gesundheitsindustrie-bw.de/en/article/news/gene-therapies-for-pulmonary-disease-are-close-to-final-development
  • Article - 08/09/2014 21988_de.jpg

    Thomas Boehm – pushing back the frontiers of knowledge

    The comparison of different animal species enables us to understand the crucial principle of immune defence on condition that the right investigative approach is chosen. Prof. Dr. Thomas Boehm director of the Max Planck Institute of Immunobiology and Epigenetics in Freiburg has been doing just this for many years. Based on insights into fundamental immune system functions Boehms research is aimed at developing new strategies for the diagnosis…

    https://www.gesundheitsindustrie-bw.de/en/article/news/thomas-boehm-pushing-back-the-frontiers-of-knowledge
  • Article - 08/09/2014 Dr. Maria Moreno-Villanueva, University of Konstanz

    Molecular effects of traumatic stress

    After a traumatic experience, people often suffer not only mental, but also physical effects. Dr. María Moreno-Villanueva from the University of Konstanz has investigated the molecular effects of traumatic stress in people and has found a higher than normal number of DNA strand breaks. In the worst cases this can lead to diseases such as cancer. However, her study also shows that successful psychotherapy can reverse DNA damage. Her findings will…

    https://www.gesundheitsindustrie-bw.de/en/article/news/molecular-effects-of-traumatic-stress
  • Guest article - 01/09/2014 21916_de.jpg

    Nina Denneler’s review of her stay in Nanjing

    Nina Denneler spent six months in the Chinese province of Jiangsu, with funding from a special China scholarship from the Baden-Württemberg Ministry of Science, Research and the Arts. The 24-year-old is a student in the Department of Technical Biology at the University of Stuttgart and was able to experience the atmosphere of a Chinese lab at the College of Biotechnology and Pharmaceutical Engineering as well as gain interesting insights about…

    https://www.gesundheitsindustrie-bw.de/en/article/news/nina-denneler-s-review-of-her-stay-in-nanjing
  • Article - 01/09/2014 20555_de.jpg

    BARK CLOTH_europe – success through saving resources

    Ecological, economical and socially sustainable - all apply to a company called BARK CLOTH_europe, which in 2013 was one of 10 companies recognised as fabric innovators by the 'LAUNCH System Challenge: Fabric'. With its biomaterial made from the bark of the African Ficus tree, the company sells an innovative material that is produced using traditional methods.

    https://www.gesundheitsindustrie-bw.de/en/article/news/bark-cloth-europe-success-through-saving-resources
  • Article - 25/08/2014 The photo shows a model vertebra and an applicator attached to it. Such models are used to test different materials as well as their positioning and application.

    Frederik Wenz - radiologist sets milestone with new surgical technique for the treatment of bone metastases

    Can painful bone metastases be treated in a targeted and quick way? Can metastases that are potentially present in the liver and kidneys be adequately treated at the same time as bone metastases? These are the questions that Professor Dr. med. Frederik Wenz from the University Medical Center Mannheim asked himself before going on to develop an innovative surgical technique. After a long development period, this technique is now recognized as an…

    https://www.gesundheitsindustrie-bw.de/en/article/news/frederik-wenz-radiologist-sets-milestone-with-new-surgical-technique-for-the-treatment-of-bone-metas
  • Press release - 20/08/2014

    uniQure acquires HAE Accelerator Winner InoCard GmbH

    Heidelberg start-up develops gene therapy for the treatment of cardiac insufficiency. UniQure N.V. pays 3 million euros in cash and shares for the acquisition additional milestone payments and future revenue shares were agreed upon.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/uniqure-acquires-hae-accelerator-winner-inocard-gmbh
  • Article - 18/08/2014 Photo of a hand holding a syringe containing a dark fluid towards a naked upper arm.

    The use of human genes as medical products

    In contrast to medications used for treating disease, gene therapy does not use chemical agents to alleviate or cure disease symptoms. Instead, it involves the introduction of a normal copy of a mutated gene to restore the function of a protein. Gene therapy could also be described as a way of restoring the body’s self-healing process. It is an extremely smart idea that enables the sustainable treatment of diseases which cannot usually be…

    https://www.gesundheitsindustrie-bw.de/en/article/news/the-use-of-human-genes-as-medical-products
  • Press release - 18/08/2014 22052_de.jpg

    Research Programme Bio-Economy: 11 projects at the University Stuttgart

    The use of sustainable raw materials is the focus of the new research programme bio-economy for which the Baden-Württemberg State Government is making 13 million Euros available. Of the total of 45 research projects recommended for funding 11 projects already approved are established at seven institutes at the University of Stuttgart these have a volume of two million Euros.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/research-programme-bio-economy-11-projects-at-the-university-stuttgart
  • Article - 18/08/2014 22032_de.jpg

    Biometry: Peter Martus works at the interface of mathematics and medicine

    It’s not computer science, but it’s close to data: Prof. Dr. Peter Martus has an in-depth knowledge of how professional biotechnology and medical statistics are generated. Prof. Martus works at the University of Tübingen where he brings his know-how to clinical trials as well as working on life sciences projects where statistical issues need to be resolved.

    https://www.gesundheitsindustrie-bw.de/en/article/news/biometry-peter-martus-works-at-the-interface-of-mathematics-and-medicine
  • Article - 18/08/2014 The photo shows 7 staff members of VAXIMM GmbH.

    VAXIMM: Vaccines that impede cancer growth

    VAXIMM GmbH, a young biotechnology company from Mannheim, Germany, specialises in the development of vaccines for cancer treatment. The company’s first product candidate, VXM01, is a live oral vaccine that targets the VEGFR-2 receptor and hence the blood supply of tumours. VXM01 is currently undergoing clinical testing in pancreatic cancer patients.

    https://www.gesundheitsindustrie-bw.de/en/article/news/vaximm-vaccines-that-impede-cancer-growth
  • Article - 11/08/2014 The photo shows a bent circuit board, chip and electronics have adapted themselves to the shape of the board.<br />

    PRONTO develops microsystems for and with companies

    Since 2010, PRONTO, a project run by the MicroTEC Südwest cluster, has been focusing on the production of innovative microsystems for application in the medical and other sectors. PRONTO provides microsystems development support up to small-scale production. Customers who are seeking to implement their ideas into concrete microsystems solutions can count on the expertise and infrastructure of four institutes.

    https://www.gesundheitsindustrie-bw.de/en/article/news/pronto-develops-microsystems-for-and-with-companies
  • Article - 11/08/2014 Photo showing a real-time PCR system in the laboratory.

    dsl-Labor: developing PCR tests for medical diagnostics

    PCR has become a common application in medical diagnostics, in areas ranging from the detection of microbes to genetic testing. The demand for new tests is huge, given that there is a seemingly endless list of applications for which PCR can be used. dsl-Labor für Molekulargenetische Diagnostik specialises in the development of PCR tests and also gives advice and training to medical laboratory personnel. Veterinarians are among the company’s major…

    https://www.gesundheitsindustrie-bw.de/en/article/news/dsl-labor-developing-pcr-tests-for-medical-diagnostics
  • Article - 04/08/2014 Figure showing how the drive system works; moving the sliders a notch forward leads to progressive elongation of the intramedullary nail and the bone. The principle is based on cooling and heating.

    A “growing” nail for lengthening bones

    The lengthening of a bone following a complicated fracture or as a result of the congenital shortening of the leg can help avoid problems that may occur in the future. The use of intramedullary nails to enable the gradual extension of the affected bone has become standard treatment. Prof. Dr.-Ing. Dr. h.c. Paul Gümpel’s group of researchers at the Konstanz University of Applied Sciences (HTWG) has developed an intramedullary nail made of a…

    https://www.gesundheitsindustrie-bw.de/en/article/news/a-growing-nail-for-lengthening-bones
  • Article - 04/08/2014 Photo showing an electron microscope image of adeno-associated viruses (AAV).

    Europe’s first gene therapy

    Scientists from the National Center for Tumour Diseases (NCT) have shown that adeno-associated viruses (AAV) do not pose a cancer risk. This conclusion is based on the analysis of several million patient cells treated with AAV and the finding that the viruses do not integrate into the patient genome. AAV is the first-ever gene therapy for clinical use in the Western world. AAV vectors could also potentially be used as prototypes for the treatment…

    https://www.gesundheitsindustrie-bw.de/en/article/news/europe-s-first-gene-therapy
  • Article - 28/07/2014 21781_de.jpg

    Successes and setbacks of clinical gene therapy

    The use of retroviral haematopoietic stem cell gene therapy to treat hereditary immunodeficiencies has achieved great success in resolving the actual symptoms of the disease, but many of the patients that underwent therapy developed leukaemia later. Effective gene therapies involving gene shuttles that do not cause cancer are therefore required. The good news is that such therapies already exist.

    https://www.gesundheitsindustrie-bw.de/en/article/news/successes-and-setbacks-of-clinical-gene-therapy
  • Guest article - 21/07/2014 21741_de.jpg

    China - experiencing something new every single day

    The Baden-Württemberg Ministry of Science, Research and the Arts finances a scholarship scheme called “Research stay for application-oriented bioscientists and biotechnologists in Shanghai and Jiangsu/China”. A recent winner of this scholarship, Felix Wertek, spent six months at the Chinese Academy of Science in Shanghai and collected first-hand impressions of Chinese laboratory practice. Here, Felix reports about his exciting time in the Chinese…

    https://www.gesundheitsindustrie-bw.de/en/article/news/china-experiencing-something-new-every-single-day
  • Article - 21/07/2014 Schematic representation of multi-scale modelling: images of a molecule, cell, lung tissue and whole body, all connected with each other by arrows.<br />

    Predicting the efficiency of cancer drugs using mathematical models

    A research consortium was established at the Stuttgart Research Center Systems Biology SRCSB at the University of Stuttgart in January 2013 with the goal of establishing models that help predict the action of targeted therapeutics. The scientists combine molecular biology experiments with complex mathematical models in order to achieve a holistic understanding of disease and therapy.

    https://www.gesundheitsindustrie-bw.de/en/article/news/predicting-the-efficiency-of-cancer-drugs-using-mathematical-models

Page 18 / 61

sb_search.block.search_result.other.pages

  • eine Seite vor
  • 1
  • …
  • 16
  • 17
  • 18
  • 19
  • 20
  • …
  • 61
  • eine Seite zurück
  • Extend search to all portals
  • Search the Healthcare industry database
  • Search the Research institutions
Search terms
Portal
Information type
  • Type
    Event date
    From
    To
  • Type
  • Publication date
    Topics
    Topics
  • Publication date
Reset

Footer navigation

  • Healthcare industry BW
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events
  • Databases
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • Project pages
    • Telemedicine BW
    • MDR & IVDR
  • Portals
    • BIOPRO BW
    • Healthcare industry
    • Bioeconomy
  • To top

stay informed

Newsletter abonnieren

Social Media

  • Xing
  • Twitter
  • LinkedIn
  • Rss
  • Privacy statement
  • Legal notice
  • Sitemap
  • Contact
© 2023
Website address: https://www.gesundheitsindustrie-bw.de/en/search